NEWS & EVENTS
A simple arm test that employs a novel wearable technology can rapidly and accurately identify physiological frailty in older adults, according to new study results. Read more at the American College of Surgeons.
Researchers at MIT and Brigham and Women’s Hospital have developed nanoparticles that can deliver anti-obesity drugs directly to fat tissue. Overweight mice treated with these nanoparticles lost 10 percent of their body weight over 25 days, without showing any negative side effects. Read more at MIT News.
Biomedical imaging professionals from around the country convened in Washington, D.C., in April for the 7th annual Medical Technology Showcase, organized by the Coalition for Imaging and Bioengineering Research (CIBR). Created by the Academy of Radiology Research in 2006, CIBR partners with patients, radiology departments, device makers, and imaging societies to educate the public and Congress about imaging research.
Investigators have found that circulating tumor cell clusters -- which are more efficient in spreading cancer throughout the body than are single CTCs -- can pass through capillary-sized blood vessels. Their findings contradict the widely-held belief that CTC clusters are too large to pass through capillaries and suggest potential strategies to reduce clusters' metastatic potential. Read the Mass General News Release.
According to new Northwestern Medicine research, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, . As a result, the allergic reaction in the airways is shut down long- term and an asthma attack prevented.Read more at Northwestern News.
Investigators report on a novel biochemical method that enables the regeneration of selected molecular constituents in situ after device implantation, which has the potential to substantially extend the lifetime of bioactive films without the need for device removal. Read more at Science Daily.
Researchers have developed a novel method to store microfluidic devices for CD4 T cell testing in extreme weather conditions for up to six months without refrigeration. If produced at a large scale, the device would cost less than $1 compared with the current cost of a CD4 assay which is about $30-$50. Read more at Science Daily.
Ary Goldberger, M.D., Roger G. Mark, M.D., Ph.D., and George Moody, founders of PhysioNet, were selected to receive the Association for the Advancement of Medical Instrumentation (AAMI) Foundation's most prestigious award, the 2016 Laufman-Greatbatch Award.
Researchers from MIT and Brigham and Women’s Hospital have designed a new type of pill that, once swallowed, can attach to the lining of the gastrointestinal tract and slowly release its contents. Read more at MIT News.